The name Gossamer Bio depicts the symbolism behind the gossamer thread, the invisible and fragile connection that binds all relationships in life. In our context, this is intended to highlight the importance of our relationships with our employees, shareholders, providers, partners and patients in a healthcare system. We take these relationships seriously and aim to continuously strengthen these connections. Gossamer Bio is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing and commercializing therapeutics in the disease areas of immunology, inflammation and oncology. Our goal is to create a business that allows value creation and capture at the individual asset level, long-term sustainability, and continuity, while ultimately helping to improve the lives of patients.
Sheila Gujrathi, M.D.
Co-Founder, Chief Executive Officer
Co-Founder, Executive Chairman
Chief Financial Officer
Luisa Salter-Cid, Ph.D.
Chief Scientific Officer
Jakob Dupont, M.D.
Chief Medical Officer
Executive Vice President and General Counsel
Vice President, Human Resources